Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Enochian Biosciences Inc (NQ: ENOB ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Aug 4, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Enochian Biosciences Inc < Previous 1 2 3 4 5 6 Next > BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) Releases CEO Shareholder Message January 16, 2024 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) CEO Featured Guest in Recent Proactive Interview November 22, 2023 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) CEO Participating in Webinar Focused on Future Health Tech October 20, 2023 Via Investor Brand Network BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) CEO Releases Shareholder Letter Regarding Agreement to Combine with Leading AI Company October 02, 2023 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) Enters Definitive Agreement to Combine with Leading AI Tech GEDi Cube September 29, 2023 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) Congratulates GEDiCube on New Joint Effort Clinical Trials August 30, 2023 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence BioMedNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) Eyes Clear Path to IND Submission for Innovative Cancer Platform August 23, 2023 Via Investor Brand Network Exposures Product Safety BioMedNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) CEO Discusses Substantial Scientific, Product Development Advances in Letter to Shareholders August 18, 2023 Via Investor Brand Network Exposures Product Safety BioMedNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) Announces Presentation of ‘Impressive’ Results from Proof-of-Concept Studies August 17, 2023 Via Investor Brand Network BioMedNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) Eyes Bright Future in Advancing Potentially Curative Therapies August 16, 2023 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property BioMedNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) Committed to Rapid Advancement of Its Proprietary Oncology Platform August 15, 2023 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property Renovaro BioSciences (NASDAQ: RENB), GEDi Cube Announce LOI to Merge, Focus on Fight Against Cancer August 09, 2023 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB), GEDi Cube Announce LOI to Merge, Focus on Fight Against Cancer August 09, 2023 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence 12 Health Care Stocks Moving In Monday's Intraday Session July 31, 2023 Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session July 19, 2023 Via Benzinga 3 Doomed Biotech Stocks Destined for Disaster July 17, 2023 Doomed biotech stocks are a major part of the natural cycle within the sector that results in a lot of failures. Via InvestorPlace Why ImmuCell Are Trading Higher; Here Are 20 Stocks Moving Premarket July 12, 2023 Gainers Cadrenal Therapeutics, Inc. (NASDAQ: CVKD) shares surged 131.6% to $4.03 in pre-market trading after gaining 15% on Tuesday. Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday July 12, 2023 It's time to start off Wednesday with an overview of all the biggest pre-market stock movers worth watching this morning! Via InvestorPlace 12 Health Care Stocks Moving In Tuesday's Pre-Market Session July 11, 2023 Via Benzinga Why Li Auto Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Monday's Mid-Day Session July 03, 2023 Gainers PolyMet Mining Corp. (NYSE: PLM) shares surged 144% to $1.92 after the company announced Glencore made a non-binding proposal to acquire the company for $2.11 per share. Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session July 03, 2023 Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session June 30, 2023 Via Benzinga Enochian BioSciences Inc. Announces Adjournment of 2023 Annual Stockholder Meeting June 23, 2023 From Enochian BioSciences, Inc. Via GlobeNewswire Stocks That Hit 52-Week Lows On Tuesday June 13, 2023 On Tuesday, 32 companies reached new 52-week lows. Via Benzinga Enochian BioSciences Announces that its Cancer Platform Remains on Track for Trials in Humans Following FDA Review June 08, 2023 From Enochian BioSciences, Inc. Via GlobeNewswire Enochian BioSciences’ CEO Letter to Shareholders April 03, 2023 Turning the Page; A Promising Future From Enochian BioSciences, Inc. Via GlobeNewswire Enochian BioSciences Announces a Scientific Presentation of Proof-of-Concept Studies for a Potential Therapy for Cancers with a Poor Life Expectancy by a Leading Researcher March 29, 2023 From Enochian BioSciences, Inc. Via GlobeNewswire Enochian BioSciences Achieves Full Compliance with NASDAQ Filing Requirements March 13, 2023 From Enochian BioSciences, Inc. Via GlobeNewswire Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Form 10-Q for the Period Ended December 31, 2022 February 23, 2023 From Enochian BioSciences, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Tuesday's Pre-Market Session February 07, 2023 Via Benzinga < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.